Secondary analysis of 7769 REPRIEVE participants with HIV: heart failure incidence was 1.65/1000 person-years over a median 5.6 years, higher in women, sub-Saharan Africa and with hypertension or obesity; observed events (67) matched predicted (73).
Secondary analysisn = 7,769
Bloomfield et al. Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)